Literature DB >> 24995204

Dancing eyes dancing feet syndrome-a report of two cases.

P Jasminekalyani1, S Saravanan2, Sriramakrishnan V3, Radha M3.   

Abstract

Opsoclonus Myoclonus (OMS) is a rare neurological disorder which appears to be the result of an autoimmune dysfunction. It is an extremely rare condition, affecting as few as 1 in 10,000,000 people every year. It affects 2 to 3% of children. Opsoclonus Myoclonus, which manifests itself as post infectious encephalopathy, occasionally along with HIV infection, post Streptococcal infection, West Nile virus encephalitis and Rickettsial infection, most often presents as a paraneoplastic syndrome, which is especially caused by occult neuroblastoma which is commonly seen in childhood and occurs in adults in relation to breast cancer and small cell lung cancer. In this study, two adult post infectious cases which had rare manifestations, have been presented. The cases were managed by using corticosteroids.

Entities:  

Keywords:  Autoimmune disorder; Opsoclonus myoclonus; Paraneoplastic syndrome; Post infectious encephalopathy

Year:  2014        PMID: 24995204      PMCID: PMC4080025          DOI: 10.7860/JCDR/2014/7184.4339

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  Adaptive control of saccades in children with dancing eye syndrome.

Authors:  Laura E Mezey; Christopher M Harris
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

2.  Childhood opsoclonus myoclonus.

Authors:  Russell C Dale
Journal:  Lancet Neurol       Date:  2003-05       Impact factor: 44.182

3.  Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.

Authors:  Wendy G Mitchell; Virdette L Brumm; Colleen G Azen; Kirsten E Patterson; Sonia K Aller; Jenny Rodriguez
Journal:  Pediatrics       Date:  2005-10       Impact factor: 7.124

4.  Myoclonic encephalopathy of infants.

Authors:  M Kinsbourne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-08       Impact factor: 10.154

5.  Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.

Authors:  K Hayward; R J Jeremy; S Jenkins; A J Barkovich; S H Gultekin; J Kramer; M Crittenden; K K Matthay
Journal:  J Pediatr       Date:  2001-10       Impact factor: 4.406

6.  Palatal myoclonus in postinfectious opsoclonus myoclonus syndrome : a case report.

Authors:  T Srivastava; A Thussu
Journal:  Neurol India       Date:  1999-06       Impact factor: 2.117

7.  Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

Authors:  R Cooper; Y Khakoo; K K Matthay; J N Lukens; R C Seeger; D O Stram; R B Gerbing; A Nakagawa; H Shimada
Journal:  Med Pediatr Oncol       Date:  2001-06

8.  Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

Authors:  E Rudnick; Y Khakoo; N L Antunes; R C Seeger; G M Brodeur; H Shimada; R B Gerbing; D O Stram; K K Matthay
Journal:  Med Pediatr Oncol       Date:  2001-06

9.  Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.

Authors:  Elizabeth D Tate; Tyler J Allison; Michael R Pranzatelli; Steven J Verhulst
Journal:  J Pediatr Oncol Nurs       Date:  2005 Jan-Feb       Impact factor: 1.636

10.  Ataxia and secretory diarrhea: two unusual paraneoplastic syndromes occurring concurrently in the same patient with ganglioneuroblastoma.

Authors:  Benjamin Gesundheit; Charles R Smith; J Ted Gerstle; Sheila S Weitzman; Helen S L Chan
Journal:  J Pediatr Hematol Oncol       Date:  2004-09       Impact factor: 1.289

View more
  2 in total

1.  Ataxia induced by a thymic neuroblastoma in the elderly patient.

Authors:  Ory Wiesel; Shamik Bhattacharyya; Henrikas Vaitkevicius; Sashank Prasad; Ciaran McNamee
Journal:  World J Surg Oncol       Date:  2015-05-12       Impact factor: 2.754

2.  Opsoclonus-myoclonus-ataxia syndrome in an HIV-infected child.

Authors:  Noella Maria Delia Pereira; Ira Shah; Shilpa Kulkarni
Journal:  Oxf Med Case Reports       Date:  2016-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.